These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21075170)

  • 1. Recruitment of the oncoprotein v-ErbA to aggresomes.
    Bondzi C; Brunner AM; Munyikwa MR; Connor CD; Simmons AN; Stephens SL; Belt PA; Roggero VR; Mavinakere MS; Hinton SD; Allison LA
    Mol Cell Endocrinol; 2011 Jan; 332(1-2):196-212. PubMed ID: 21075170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibition drives HDAC6-dependent recruitment of tau to aggresomes.
    Guthrie CR; Kraemer BC
    J Mol Neurosci; 2011 Sep; 45(1):32-41. PubMed ID: 21340680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer promoted by the oncoprotein v-ErbA may be due to subcellular mislocalization of nuclear receptors.
    Bonamy GM; Guiochon-Mantel A; Allison LA
    Mol Endocrinol; 2005 May; 19(5):1213-30. PubMed ID: 15650025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
    Harbers M; Wahlström GM; Vennström B
    J Steroid Biochem Mol Biol; 1998 Nov; 67(3):181-91. PubMed ID: 9879977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the v-erbA protein is required for its function as an oncogene.
    Glineur C; Zenke M; Beug H; Ghysdael J
    Genes Dev; 1990 Oct; 4(10):1663-76. PubMed ID: 1979040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear export of the oncoprotein v-ErbA is mediated by acquisition of a viral nuclear export sequence.
    DeLong LJ; Bonamy GM; Fink EN; Allison LA
    J Biol Chem; 2004 Apr; 279(15):15356-67. PubMed ID: 14729678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
    Wahlström GM; Harbers M; Vennström B
    Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic dynein/dynactin mediates the assembly of aggresomes.
    Johnston JA; Illing ME; Kopito RR
    Cell Motil Cytoskeleton; 2002 Sep; 53(1):26-38. PubMed ID: 12211113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequences required for the transition from monomeric to homodimeric forms of thyroid hormone receptor alpha and v-erbA.
    Zubkova I; Subauste JS
    Mol Cell Endocrinol; 2003 Jan; 199(1-2):61-72. PubMed ID: 12581880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera.
    García-Mata R; Bebök Z; Sorscher EJ; Sztul ES
    J Cell Biol; 1999 Sep; 146(6):1239-54. PubMed ID: 10491388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
    Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
    EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct binding with histone deacetylase 6 mediates the reversible recruitment of parkin to the centrosome.
    Jiang Q; Ren Y; Feng J
    J Neurosci; 2008 Nov; 28(48):12993-3002. PubMed ID: 19036992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.
    Selmi S; Samuels HH
    J Biol Chem; 1991 Jun; 266(18):11589-93. PubMed ID: 1675637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway.
    Urnov FD; Yee J; Sachs L; Collingwood TN; Bauer A; Beug H; Shi YB; Wolffe AP
    EMBO J; 2000 Aug; 19(15):4074-90. PubMed ID: 10921888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII.
    Disela C; Glineur C; Bugge T; Sap J; Stengl G; Dodgson J; Stunnenberg H; Beug H; Zenke M
    Genes Dev; 1991 Nov; 5(11):2033-47. PubMed ID: 1682217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of v-ErbA with Smad4 disrupts TGF-beta signaling.
    Erickson RA; Liu X
    Mol Biol Cell; 2009 Mar; 20(5):1509-19. PubMed ID: 19144825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
    Rascle A; Ferrand N; Gandrillon O; Samarut J
    Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presenilin 1 forms aggresomal deposits in response to heat shock.
    Kovacs I; Lentini KM; Ingano LM; Kovacs DM
    J Mol Neurosci; 2006; 29(1):9-19. PubMed ID: 16757805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains.
    Hao R; Nanduri P; Rao Y; Panichelli RS; Ito A; Yoshida M; Yao TP
    Mol Cell; 2013 Sep; 51(6):819-28. PubMed ID: 24035499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
    Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
    Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.